Josephine Adams
Family · Beavercreek, OHNPI 1730621780
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.9% of the total across 281 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,563 and has fallen 87.6% since, to $318 in 2024. Among family clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 281 payments — averaging $18.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$764
- Jazz Pharmaceuticals Inc.$755
- AbbVie$685
- Amgen$409
- Lilly USA, LLC$378
- Boehringer Ingelheim$367
- plus $2K from 21 others
What the payments were for
- Food & beverage$5,183100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 22 | $764 |
| Jazz Pharmaceuticals Inc. | 47 | $755 |
| AbbVie | 46 | $685 |
| Amgen | 21 | $409 |
| Lilly USA, LLC | 26 | $378 |
| Boehringer Ingelheim | 22 | $367 |
| Pfizer | 23 | $362 |
| BD | 3 | $297 |
| Amarin Pharma, Inc. | 17 | $228 |
| Novo Nordisk | 11 | $198 |
| Abbott | 8 | $148 |
| Otsuka America Pharmaceutical, Inc. | 6 | $143 |
| Biohaven Pharmaceuticals, Inc. | 5 | $71 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $62 |
| Novartis | 3 | $62 |
| Esperion Therapeutics, Inc. | 3 | $53 |
| GSK | 3 | $40 |
| Eisai Inc. | 2 | $37 |
| Gilead | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $16 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $16 |
| Exact Sciences | 1 | $14 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
| Evoke Pharma, Inc. | 1 | $13 |
| Merck | 1 | $12 |
| Kowa Pharmaceuticals America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BREZTRI$234
- ARISTA AH FLEXITIP$126
- MOUNJARO$104
- XYWAV$104
How this compares
$5,189 in reported general payments places this provider in the 90th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 12 | $18 |
| Allopurinol | 12 | $16 |
| Glipizide | 12 | $10 |
| Metformin Hcl | 12 | $7 |
Paid to pharmacies, not to this prescriber.
Other family in Beavercreek
- Jenna McConnellBeavercreek$15K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.